Editor's Comparative Analysis
When choosing between ESMO Real World Data and Digital Oncology and Libri Oncologici, researchers should consider the trade-off between prestige (Libri Oncologici leads with an IF of ) and cost-efficiency, as Libri Oncologici is a Diamond Open Access venue.
ESMO Real World Data and Digital Oncology is published in GB, while Libri Oncologici is headquartered in HR. Both titles are verified via the JournalsHub Live Indexing Tracker for 2026.
| Academic Metric | ESMO Real World Data and Digital Oncology | Libri Oncologici |
|---|---|---|
| General Information | ||
| Publisher | Elsevier | University Hospital for Tumors |
| Country of Origin | GB | HR |
| Established | 2024 | 2020 |
| Editor-in-Chief | See Website | See Website |
| Scientific Influence | ||
| Current Impact Factor | N/A | N/A |
| Indexing Status |
DOAJ
|
DOAJ
|
| Review Speed (Decision) |
87 days
Standard
|
Unknown |
| Acceptance Rate | N/A | N/A |
| Access & Publication Fees | ||
| Open Access Type | Full OA | Full OA |
| APC Fee (Estimated) | $2,750.00 | FREE (Diamond) |
Historical Impact Factor Comparison
No historical impact factor data available for these journals yet.
About ESMO Real World Data and Digital Oncology
ESMO Real World Data and Digital Oncology is a prominent academic journal specializing in Neoplasms. Tumors. Oncology. Including cancer and carcinogens. Published by Elsevier in GB, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified by ISSN 2949-8201. …
View Full ProfileAbout Libri Oncologici
Libri Oncologici is a prominent academic journal specializing in Neoplasms. Tumors. Oncology. Including cancer and carcinogens. Published by University Hospital for Tumors in HR, the journal serves as an essential platform for researchers to share high-quality scholarly work. It is fully Open Access publication identified by ISSN 0300-8142. The journal …
View Full ProfileSearching for: ESMO Real World Data and Digital Oncology impact factor, Libri Oncologici APC fees, journal comparison tool 2026.